	Longitudinal magnetic resonance spectroscopy study of metabolite changes over 2â€‰years in relapsing and primary progressive multiple sclerosis treated with ocrelizumab. Mult Scler MacMillan EL, Russell-Schulz B, Alejo G, Harp C, Cameron B, Winger R, Jia S, Herman A, Kassam J, Waine M, Vavasour IM, Cross H, Tam R, Traboulsee AL, Carruthers R, Kolind SH. PMID: 42376811 [PubMed - as supplied by publisher]
	Intrathecal synthesis of antiviral IgG antibodies in multiple sclerosis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub Licha K, Kusnierova P, Revendova KZ, Thon V, Zeman D. PMID: 42374901 [PubMed - as supplied by publisher]
	Efficacy and safety of ofatumumab in participants with relapsing multiple sclerosis and breakthrough disease on oral fingolimod or fumarates: results from the ARTIOS study. J Neurol Bove R, Langdon D, Maciejowski M, Jasi, Dufek M, Abeyewickreme A, Rauh A, Fu H, Khan IA, Böhringer M, Eichau SM, Derfuss T. PMID: 42371147 [PubMed - indexed for MEDLINE]
	Effects of transcranial direct current stimulation in multiple sclerosis: Recent findings of clinical studies and animal models. Acta Neurobiol Exp (Wars) Hashemi M, Tajik MH, Javanbakht P, Taghizadeh F, Zarini D, Mojaverrostami S. PMID: 42370615 [PubMed - indexed for MEDLINE]
	Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trial. Health Technol Assess Williams T, Blackstone J, John N, Braisher M, De Angelis F, Bianchi A, Calvi A, Doshi A, Mangion SA, Wade C, Bordea E, Merry R, Barton G, Lyle D, Jarman E, Mahad D, Shehu A, Arun T, McDonnell G, Geraldes R, Craner M, Hillier C, Ganesalingam J, Fisniku L, Hobart J, Spilker C, Robertson NP, Kalra S, Pluchino S, Harikrishnan S, Mattoscio M, Harrower T, Young C, Lee M, Chhetri SK, Ahmed F, Rog D, Silber E, Gallagher P, Duddy M, Straukiene A, Nicholas R, Rice C, Tebbs S, Hawton A, Hunter R, Giovannoni G, Ciccarelli O, Beveridge J, Nixon S, Thompson AJ, Greenwood J, Pearson O, Evangelou N, Sharrack B, Galea I, Pavitt S, Chandran S, Ford HL, Nicholas JM, Chataway J, MS-STAT2 Investigators. PMID: 42370465 [PubMed - indexed for MEDLINE]
	Correlation Is Not Prediction: Reassessing Predictive MRI Evidence in Guidelines for Persons With Relapsing-Remitting Multiple Sclerosis. J Cent Nerv Syst Dis Minas D, Buchka S, Havla J, Mansmann U. PMID: 42369642 [PubMed]
	The effect of a web-based self-care education programme on the health-promoting behaviours of patients with multiple sclerosis: a randomised controlled trial. J Res Nurs Akbari S, Amini K, Gheiasi SF, Hanifi N. PMID: 42368038 [PubMed - as supplied by publisher]
	Modulation of the immunological and neuroinflammatory microenvironment in older people with multiple sclerosis. Front Immunol Oreja-Guevara C, Meuth SG, Grigoriadis N, Vermersch P, Hartung HP, Sörensen PS, Leocani L, Schmierer K, Gold R, Fernández Ó. PMID: 42367807 [PubMed - indexed for MEDLINE]
	Palm Cooling's Heart Rate and Thermal Impact on Exercise in Multiple Sclerosis Patients. Sports Med Int Open Maguire KF, Wydotis M, Jaggers J, Quesada P, Daily J, Cabrera-Rojas Y, Caruso JF. PMID: 42367317 [PubMed]
	Immune Cells as Mediators Between Gut Microbiota and Multiple Sclerosis: Insights From Mendelian Randomization. Immun Inflamm Dis Ning P, Mu X, Zhang X, Liu Y, Yuan R, Tang P, Li R. PMID: 42366904 [PubMed - indexed for MEDLINE]
	Microstructural changes in juxtacortical white matter regions and their relationship with PASAT score in multiple sclerosis: A proof of concept using machine learning. Mult Scler Relat Disord Montalba C, Franco P, Caulier-Cisterna R, Cruz JP, Cárcamo C, Andia ME, Ciampi E. PMID: 42365747 [PubMed - as supplied by publisher]
	Current perspectives on the pathogenesis of multiple sclerosis: A minireview. Endocr Regul Radikova Z, Tibensky M, Mosna L, Penesova A, Havranova A, Vlcek M, Imrich R. PMID: 42365629 [PubMed - indexed for MEDLINE]
	Predictors of early response to cladribine in mexican patients with multiple sclerosis: A real world multicenter retrospective cohort study. Mult Scler Relat Disord Moreno-Bernardino CJ, Treviño-Frenk I, Ortiz-Maldonado JF, Sánchez-Rosales NA, Skromne-Eisenberg E, Cortés-Enriquez F, Sauri-Suarez S, Del León-Murillo A, Bazan-Rodríguez AL, Torres-Mora C, Gómez-Figueroa E. PMID: 42364569 [PubMed - as supplied by publisher]
	Economic and social burden of multiple sclerosis in Morocco: a tertiary care center study. Mult Scler Relat Disord El Otmani H, Simma K, El Omari H, Sikkal A, Khattab H, Haddouali K, Bellakhdar S, El Moutawakil B, Rafai MA. PMID: 42364566 [PubMed - as supplied by publisher]
	Is serum neurofilament light chain accurate enough to guide multiple sclerosis care? Diagnostic performance and optimal cutoff in a systematic review and meta-analysis. Mult Scler Relat Disord Santana JLS, Themoteo RM, Allioni GA, Marzano LAS, Bernal HM, Veiga ML, Sales ABL, Apóstolos-Pereira SL, Adoni T, Callegaro D, Silva GD. PMID: 42364564 [PubMed - as supplied by publisher]
	Utility of Multi-Analyte Protein Assay to Distinguish Multiple Sclerosis Clinical Relapse from Pseudoexacerbation. Neurol Ther Okuda DT, Moog TM, McCreary MC, Huddleston IJ, Wright CM, Burgess KW, Santoyo JR, Sguigna PV, Stüve O, Tran DH. PMID: 42364069 [PubMed - as supplied by publisher]
	Neurogenic bowel dysfunction in multiple sclerosis: clinical determinants and its association with bladder dysfunction in a multicenter study. Arch Phys Med Rehabil Akkoç Y, Y, Adanur H, Tunç H, Alemdaro, Kany, Özlü A, Gök H, Erhan B, Özdolap , Bardak AN, , Zinnuro, Karaman B, Yüceyar AN, Ekmekçi Ö, Bir LS, Ak, Öztürk SM, Özi, Canbulat AT, Demiral GZ, Kabay SC, Güne, Yücesan C, Emir C, Yumu, Cantürk , Güne, Paker N, Bu, Güzel NB, Küçükçak, Koçer B, Orbak ES, Kökmen H. PMID: 42362078 [PubMed - as supplied by publisher]
	Fingolimod for pediatric multiple sclerosis: The Ped-MS group systematic review and meta-analysis. Mult Scler Relat Disord Kaveyee H, Etemadifar M, Abhari AP, Ramezani A, Ebne-Ali-Heydari Y, Miralaei P, Norouzi M, Eshraghi R, Salari M, Deputy S. PMID: 42361660 [PubMed - as supplied by publisher]
	Serum IDO1 and Î²-catenin levels in patients with multiple sclerosis with and without atherosclerosis: A case-control study. J Neuroimmunol Abdulridha GAO, Fadhel AS, Al-Kinany SQ, Makki NF. PMID: 42361476 [PubMed - as supplied by publisher]
	Global Access to Diagnostic Paraclinical Testing Incorporated in the 2024 Revised McDonald Criteria: Disparities and Opportunity. Neurol Clin Pract Solomon AJ, Zakaria M, Saylor DR, Viswanathan S, Czarnota-Sza, Banwell BL, Coetzee T, Montalban X, Hillman N, Shinohara RT, Rijke N, Helme AE, King R. PMID: 42361331 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 44364

Page 1 of 2219



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy